Respiratory viruses: New frontiers-a Keystone Symposia report

Ann N Y Acad Sci. 2023 Apr;1522(1):60-73. doi: 10.1111/nyas.14958. Epub 2023 Feb 1.

Abstract

Respiratory viruses are a common cause of morbidity and mortality around the world. Viruses like influenza, RSV, and most recently SARS-CoV-2 can rapidly spread through a population, causing acute infection and, in vulnerable populations, severe or chronic disease. Developing effective treatment and prevention strategies often becomes a race against ever-evolving viruses that develop resistance, leaving therapy efficacy either short-lived or relevant for specific viral strains. On June 29 to July 2, 2022, researchers met for the Keystone symposium "Respiratory Viruses: New Frontiers." Researchers presented new insights into viral biology and virus-host interactions to understand the mechanisms of disease and identify novel treatment and prevention approaches that are effective, durable, and broad.

Keywords: COVID-19; RSV; adaptive immunity; influenza virus; innate immunity; respiratory virus.

Publication types

  • Congress
  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • COVID-19* / pathology
  • COVID-19* / virology
  • Host Microbial Interactions
  • Humans
  • Influenza, Human* / pathology
  • Influenza, Human* / virology
  • Respiratory Syncytial Virus Infections* / pathology
  • Respiratory Syncytial Virus Infections* / virology
  • Respiratory Syncytial Viruses
  • SARS-CoV-2